Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer. (Q44572714)
Jump to navigation
Jump to search
scientific article published in September 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer. |
scientific article published in September 2003 |
Statements
Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer (English)
R Paridaens
L Dirix
C Lohrisch
L Beex
M Nooij
D Cameron
T Cufer
L Duchateau
A Hamilton
J P Lobelle
M Piccart
European Organization for the Research and Treatment of Cancer (EORTC)- Investigational Drug Branch for Breast Cancer (IDBBC)
1 September 2003